These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 11229538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines.
    Bae JY, Ahn SJ, Han W, Noh DY.
    J Cell Biochem; 2007 Jul 01; 101(4):1038-45. PubMed ID: 17163455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death.
    Yo YD, Chung YM, Park JK, Ahn CM, Kim SK, Kim HJ.
    Exp Mol Med; 2002 Sep 30; 34(4):273-7. PubMed ID: 12515392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antisense of human peroxiredoxin II enhances radiation-induced cell death.
    Park SH, Chung YM, Lee YS, Kim HJ, Kim JS, Chae HZ, Yoo YD.
    Clin Cancer Res; 2000 Dec 30; 6(12):4915-20. PubMed ID: 11156252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Peroxiredoxins in breast carcinoma.
    Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y.
    Clin Cancer Res; 2003 Aug 15; 9(9):3418-24. PubMed ID: 12960131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peroxiredoxins in inflammatory liver diseases and ischemic/reperfusion injury in liver transplantation.
    Lu D, Wang W, Liu J, Qi L, Zhuang R, Zhuo J, Zhang X, Xu X, Zheng S.
    Food Chem Toxicol; 2018 Mar 15; 113():83-89. PubMed ID: 29360557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased expression of peroxiredoxin II confers resistance to cisplatin.
    Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ.
    Anticancer Res; 2001 Mar 15; 21(2A):1129-33. PubMed ID: 11396151
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species.
    Wong CM, Chun AC, Kok KH, Zhou Y, Fung PC, Kung HF, Jeang KT, Jin DY.
    Antioxid Redox Signal; 2000 Mar 15; 2(3):507-18. PubMed ID: 11229364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.